HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Perthes' disease in scintigraphy - early diagnosis, course and therapeutic consequences].

Abstract
A four year study on radionuclide imaging in Perthes's disease is reported. The results reveal that radionuclide imaging facilitates the earliest diagnosis possible as well as the differentiation against other affections of the hip. In eleven cases (diagnoses ascertained by X-ray follow up or biopsy) the duration of the course of Perthes' disease was shortened and the ultimate outcome was improved because of the early onset of therapy. Follow up examinations with radionuclide imaging and quantification of uptake reveal the extent of revascularisation of the necrosis of the femoral head and the epiphyseal plate at any point in time during the course of the disease. This leads to prognostic and therapeutic consequences, particularly in view of expected head at risk signs in the development of Perthes' disease.
AuthorsG Ritter
JournalZeitschrift fur Orthopadie und ihre Grenzgebiete (Z Orthop Ihre Grenzgeb) 1982 Nov-Dec Vol. 120 Issue 6 Pg. 850-9 ISSN: 0044-3220 [Print] Germany
Vernacular TitleDer Morbus Perthes in der Szintigraphie -- Frühdiagnose, Verlauf und therapeutische Konsequenzen.
PMID6219506 (Publication Type: Journal Article)
Chemical References
  • Diphosphonates
  • Technetium
  • Technetium Tc 99m Medronate
Topics
  • Adolescent
  • Casts, Surgical
  • Child
  • Child, Preschool
  • Diagnosis, Differential
  • Diphosphonates
  • Female
  • Femur Head (diagnostic imaging)
  • Femur Head Necrosis (diagnostic imaging)
  • Hip Joint (diagnostic imaging)
  • Humans
  • Joint Diseases (diagnostic imaging)
  • Legg-Calve-Perthes Disease (diagnostic imaging, therapy)
  • Male
  • Radiography
  • Radionuclide Imaging
  • Technetium
  • Technetium Tc 99m Medronate
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: